trivalent flu vaccine

[Constituents and Characters]

The vaccine is prepared from influenza virus type A and B prevalent strains recommended by WHO. The virus strains are propagated in embryonated chicken eggs. After incubation, the virus suspensions in allantoic cavities are harvested. The vaccine is prepared by inactivation, concentration, purification and splitting. The vaccine is a slightly opalescent liquid.

[Vaccination Subjects]

The vaccine is approved for use in vulnerable people and high risk population for inf1uenza complications, such as children over 3 years of age, the elderly, the weak and people in influenza epidemic areas.

[Function and Use]

It is indicated for active immunization against influenza disease caused by influenza virus subtypes A and type B contained in the vaccine for prophylaxis of the Influenza caused by the contained vaccine strain.

[Specifications]

This vaccine per single human dose is 0.5ml in syringe containing not lower than 15µg HA for each virus strain.